CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.
In: Acta Oncologica, Jg. 60 (2021-11-01), Heft 11, S. 1543-1547
academicJournal
Zugriff:
The article discusses CXCR4 and hif-alpha as prognostic molecular markers for stage three colon cancer patients. Topics discussed include biomarkers for adjuvant treatment to further improve patients' survival; aim to analyse the regulatory mechanisms of tumour microenvironment (TME); and use of Kaplan–Meier method and log-rank tests for survival analysis.
Titel: |
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.
|
---|---|
Autor/in / Beteiligte Person: | Maderer, Annett ; Fiteni, Frederic ; Tanis, Erik ; Mauer, Murielle ; Schmitt, Thomas ; Aust, Daniela E. ; Lutz, Manfred P. ; Roelofson, Felicitas ; Gog, Christiane ; Weinmann, Arndt ; Koehne, Claus H. ; Moehler, Markus ; Thomaidis, Thomas |
Zeitschrift: | Acta Oncologica, Jg. 60 (2021-11-01), Heft 11, S. 1543-1547 |
Veröffentlichung: | 2021 |
Medientyp: | academicJournal |
ISSN: | 0284-186X (print) |
DOI: | 10.1080/0284186X.2021.1959057 |
Schlagwort: |
|
Sonstiges: |
|